Operating Lease, Right-of-Use Asset of CERO THERAPEUTICS HOLDINGS, INC. from 31 Dec 2023 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
CERO THERAPEUTICS HOLDINGS, INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2023 to 30 Sep 2025.
  • CERO THERAPEUTICS HOLDINGS, INC. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $869,538, a 47% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

CERO THERAPEUTICS HOLDINGS, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $869,538 -$783,076 -47% 30 Sep 2025 10-Q 19 Nov 2025 2025 Q3
Q2 2025 $1,072,950 -$763,149 -42% 30 Jun 2025 10-Q 22 Aug 2025 2025 Q2
Q1 2025 $1,271,186 -$743,861 -37% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $1,464,367 -$725,198 -33% 31 Dec 2024 10-Q 19 Nov 2025 2025 Q3
Q3 2024 $1,652,614 30 Sep 2024 10-Q/A 20 Nov 2024 2024 Q3
Q2 2024 $1,836,099 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $2,015,047 31 Mar 2024 10-Q 17 May 2024 2024 Q1
Q4 2023 $2,189,565 31 Dec 2023 10-K 15 Apr 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.